Yes, a real and well-documented disparity exists.

In the largest US study, African American women reported hot flashes most frequently of all racial and ethnic groups studied and had the longest total duration, about 10.1 years compared with 7.4 years overall. This burden is compounded by a documented treatment gap. A now-discredited historical belief, that higher body weight in Black women supplied enough peripheral estrogen to make their symptoms milder, was taught in medical training and was incorrect. The true mechanisms behind the disparity, including chronic stress, higher rates of early hysterectomy, access, and bias, are still being worked out.

What to know about this answer

The epidemiologic disparity itself, earlier onset, greater severity, longer duration, is well documented. What remains genuinely unresolved is the underlying mechanism and the precise scale of the associated treatment gap, which currently rests more on clinical synthesis than on a single definitive study.

What the research shows, and which source each finding rests on

African American women in SWAN reported vasomotor symptoms most frequently of all racial and ethnic groups studied (adjusted OR 1.63, 95 percent CI 1.21-2.20, versus White women) and had the longest total duration of frequent symptoms, a median of 10.1 years versus 7.4 years overall

C[1]C[2]

SWAN risk factor data show higher BMI and smoking were independently associated with greater vasomotor symptom burden, factors relevant to understanding population-level disparities alongside race and ethnicity itself

C[1]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

Chronic stress and structural factors, not biology, likely drive the gap

Sharon Malone, drawing on the SWAN epidemiology and her own clinical and historical account

She recounts being taught in medical school that Black women had milder hot flashes because higher body weight supplied peripheral estrogen, a belief she states plainly was not correct, and instead points to proposed mechanisms including chronic stress, higher rates of early hysterectomy or oophorectomy, and access and bias, while noting these remain unresolved rather than settled science.

C[1]C[2]

What would settle it: Dedicated mechanistic and health-equity research separating biological, socioeconomic, stress-related, and access or bias contributions to the disparity, along with better-quantified data on the treatment gap itself.

What is really going on here

  1. For Black women specifically: am I being offered the same menu of treatment options? Earlier onset, more severe, and longer-lasting symptoms coexist with lower documented treatment rates.

Questions for your doctor

  1. Given the documented disparity, are all treatment options, hormonal and nonhormonal, being offered to me equally?
  2. How does my personal onset age and symptom severity compare to what predicts a longer duration?
  3. Should we discuss my care with these disparities specifically in mind?
  4. What support exists if I feel my symptoms have been minimized?

Questions with no answer yet

Is the true mechanism behind Black women's earlier onset, greater severity, and longer duration of hot flashes primarily biological, primarily the product of chronic stress and structural inequities, or some combination, and in what proportion?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: Chronic stress and weathering, higher rates of early hysterectomy or oophorectomy, and access and bias are proposed mechanisms, explicitly described as unresolved rather than settled, without a study quantifying how much each contributes.

What would test it: Dedicated mechanistic and health-equity research statistically separating biological, socioeconomic, stress-related, and access or bias contributions to the disparity.

How large is the treatment gap, precisely, for Black women with comparable symptom severity to white women, measured in a study designed specifically to test that comparison rather than drawn from general clinical synthesis?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The claim that Black women are about half as likely to be offered treatment is drawn from the disparities literature and clinical synthesis rather than from one dedicated, precisely designed study measuring treatment offer rates at matched symptom severity.

What would test it: A study directly comparing treatment offer and prescribing rates between Black and white women matched for symptom type, frequency, and severity.

Now that the incorrect medical-school teaching, that higher body weight in Black women supplied protective peripheral estrogen, has been identified as wrong, has that belief been formally removed from medical curricula, or does it still circulate informally in practice?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: This incorrect historical teaching is documented from personal medical training experience, without a formal audit of current medical curricula or clinician surveys establishing whether the belief still circulates.

What would test it: A survey of current medical trainees and practicing clinicians to check whether this specific incorrect belief persists.

Sources

  1. 1.Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.Gold EB et al., Am J Public Health 2006 · Observational study
  2. 2.Duration of menopausal vasomotor symptoms over the menopause transition.Avis NE et al., JAMA Intern Med 2015 · Observational study

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides